Esther de Boer

Safety and Tumor Specificity of Cetuximab-IRDye800 for Surgical Navigation in Head and Neck Cancer

Eben L. Rosenthal, Jason M. Warram, Esther de Boer et al. · Clinical Cancer Research · 2015 · 478 citations

Medicine, Oncology, Pharmacology +15

Mouse <i>Sycp1</i> functions in synaptonemal complex assembly, meiotic recombination, and XY body formation

Femke A.T. de Vries, Esther de Boer, Mike van den Bosch et al. · Genes & Development · 2005 · 469 citations · Full text

Life Sciences, Cell Biology, Genetics +17

Tumor-Specific Uptake of Fluorescent Bevacizumab–IRDye800CW Microdosing in Patients with Primary Breast Cancer: A Phase I Feasibility Study

Laetitia E. Lamberts, Maximillian Koch, Johannes S. de Jong et al. · Clinical Cancer Research · 2016 · 285 citations · Full text

Medicine, Oncology, Pharmacokinetics +17

A transistor-like pH nanoprobe for tumour detection and image-guided surgery

Tian Zhao, Gang Huang, Yang Li et al. · Nature Biomedical Engineering · 2016 · 206 citations · Full text

Engineering, Bioengineering, Biomedical Engineering +16

Safety of panitumumab-IRDye800CW and cetuximab-IRDye800CW for fluorescence-guided surgical navigation in head and neck cancers

Rebecca W. Gao, Nutte Teraphongphom, Esther de Boer et al. · Theranostics · 2018 · 187 citations · Full text

Medicine, Oncology, Pharmacology +15